Order results by:
Issue | Title | |
Vol 16, No 2 (2023) | Methodological approach to the formation of the list of high-tech medical care types | Abstract similar documents |
I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy | ||
"... groups (DRGs), on the one hand, significantly expanded the availability of HTMC methods ..." | ||
Vol 12, No 3 (2019) | Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 | Abstract similar documents |
D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh | ||
"... The article addresses the model of diagnosis-related groups (DRG) updated according to the new ..." | ||
Vol 17, No 2 (2024) | Methodology of forming a model of diagnosis-related groups for cases of medical care using surgery performed by laparoscopic access | Abstract similar documents |
I. A. Zheleznyakova, O. A. Volkova, E. I. Rumiantseva, I. A. Mikhailov, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, T. S. Vakhrusheva, E. S. Samsonova, V. V. Omelyanovskiy | ||
"... of diagnosis-related groups (DRGs) for cases of surgical medical care provided by laparoscopic access ..." | ||
Vol 16, No 2 (2023) | Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 | Abstract similar documents |
V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova | ||
"... -related groups (DRG) with the use of interferon-containing drugs as etiotropic therapy, which has been ..." | ||
Vol 17, No 4 (2024) | Development of a classification of anesthetic management methods and protocols for calculating financial costs | Abstract similar documents |
D. V. Lukyantseva, J. A. Agafonova, V. V. Omelyanovskiy, S. A. Kovaleva, D. V. Fedyaev, I. N. Pasechnik, V. V. Schukin, D. S. Blinov, A. B. Abrosimov | ||
"... in the expense structure of medical services, diagnosis-related groups (DRGs), and high-tech medical care (HMC ..." | ||
Vol 13, No 3 (2020) | The review of the foreign experience on the financing of innovative medical technologies | Abstract similar documents |
V. V. Omelyanovskiy, I. A. Zheleznyakova, T. P. Bezdenezhnykh, M. L. Lazareva, D. V. Fedyaev | ||
"... -related groups (DRG) does not contribute to the implementation of innovations in the medical practice ..." | ||
Vol 14, No 2 (2021) | Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region | Abstract similar documents |
A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin | ||
"... drugs (bDMDs) within the constraints of diagnosis-related groups (DRGs) on the level of the Moscow ..." | ||
Vol 15, No 1 (2022) | Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation | Abstract similar documents |
T. O. Bessonova, F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova, V. V. Omelyanovskiy, S. N. Krivolapov, N. M. Neminushchiy, A. A. Kalemberg | ||
"... lower ICD implantation prices resulted in an average ICER drop by 13% compared to HTMC 2. Overall ..." | ||
Vol 14, No 2 (2021) | Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting | Abstract similar documents |
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov | ||
"... (DRG), except for cases with a maximum duration in a day hospital setting. An analysis of the RDC lists ..." | ||
Vol 11, No 3 (2018) | What is the role of antineoplastic drug safety in reimbursement decision making? | Abstract similar documents |
A. S. Kolbin, A. A. Kurylev | ||
"... , поданных для включения в ограничительные лекарственные перечни в Российской Федерации, в период с 2014 по ..." | ||
Vol 17, No 3 (2024) | Approaches to developing mechanisms for medical care centralization at the interterritorial level | Abstract similar documents |
D. V. Fedyaev, F. S. Nikitin, S. A. Kovaleva, V. V. Omelyanovskiy | ||
"... and diagnosis-related groups (DRGs) of diseases, which potentially require centralization were developed ..." | ||
Vol 11, No 2 (2018) | Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations | Abstract similar documents |
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov | ||
"... Модель финансирования медицинской помощи по клинико-статистическим группам (КСГ) в 2018 г ..." | ||
Vol 13, No 3 (2020) | The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups | Abstract similar documents |
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan | ||
"... Diagnosis-Related Groups (DRG) for the payment for biological therapy were created at the stage ..." | ||
Vol 10, No 4 (2017) | THE STATE GUARANTEES PROGRAM OF FREE MEDICAL CARE: APPROACHES TO STANDARDIZE THE COSTS OF MEDICAL CARE | Abstract similar documents |
Yu. A. Ledovskikh, E. V. Semakova, M. V. Avksent’eva | ||
Vol 9, No 1 (2016) | REVIEW OF HEALTH SYSTEM ORGANIZATION APPROACHES TO ESTIMATING SERVICE LEVELS AND EXPENDITURES FOR INPATIENT CARE SERVICES | Abstract similar documents |
K. V. Gerasimova, D. V. Fedyaev, M. V. Sura, A. A. Tikhonova, V. V. Omelyanovskiy, M. V. Avksentyeva | ||
"... is based on per case of treatment for a relevant group of diseases (diagnosis related group (DRG ..." | ||
Vol 14, No 1 (2021) | Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy | Abstract similar documents |
V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov | ||
"... Цель: разработка и апробация методики сравнительного анализа перечней лекарственных препаратов (ЛП ..." | ||
Vol 9, No 1 (2016) | MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 | Abstract similar documents |
A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum | ||
"... математические линейные модели. Цель. Построение модели по данным анализа перечней на 2016 г. Материалы и ..." | ||
Vol 10, No 1 (2017) | RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION | Abstract similar documents |
M. V. Sura | ||
"... , источники финансирования перечней лекарственных препаратов, оказывающих наиболее существенное влияние на ..." | ||
Vol 13, No 2 (2020) | Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 | Abstract similar documents |
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan | ||
"... Совершенствование порядка формирования перечней лекарственных препаратов для медицинского ..." | ||
Vol 11, No 3 (2018) | The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia | Abstract similar documents |
V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina | ||
"... перспектив совершенствования принципов формирования ограничительных перечней в РФ. Сделано заключение о том ..." | ||
Vol 11, No 4 (2018) | Patient registers and account registries of compulsory medical insurance: integration and replaceability | Abstract similar documents |
I. A. Zheleznyakova, G. I. Pirova, E. A. Proxorovich | ||
Vol 8, No 2 (2015) | PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS | Abstract similar documents |
Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova | ||
"... ограничительных перечней на различных уровнях системы здравоохранения. В статье рассматривается методология ..." | ||
Vol 9, No 3 (2016) | EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS | Abstract similar documents |
N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova | ||
"... включения технологии (лекарственного препарата) в ограничительные перечни, а также определить приемлемую для ..." | ||
Vol 11, No 4 (2018) | Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions | Abstract similar documents |
G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina | ||
"... анализе затрат на терапию по видам высокотехнологичной медицинской помощи (ВМП). Заключение. Таким образом ..." | ||
Vol 13, No 2 (2020) | Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union | Abstract similar documents |
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich | ||
"... ; сравнение перечня референтных стран, понижающих коэффициентов. Результаты. Выявлены различия в процедурах ..." | ||
Vol 9, No 3 (2016) | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY | Abstract similar documents |
M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov | ||
"... препаратов, включенных и не включенных в стандарты медицинской помощи, перечни лекарственных препаратов ..." | ||
Vol 18, No 2 (2025) | Data analysis of medicines aimed at health technology assessment within the activities of the “Circle of Kindness” Foundation from 2021 to 2024 | Abstract similar documents |
V. V. Omelyanovskiy, A. A. Kingshott, T. S. Teptsova, P. A. Mukhortova, A. G. Kharitonova, S. I. Zinadinov, L. O. Krekhtunova, N. A. Aldushchenko, A. А. Kozak, V. A. Ryagina | ||
"... при принятии решений о включении заболеваний в перечень заболеваний и ЛП в перечни для закупок Фонда ..." | ||
Vol 12, No 2 (2019) | Health technology assessment and reimbursement of pharmaceuticals in Italy | Abstract similar documents |
F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
"... формирование национального перечня возмещаемых препаратов. В некоторых регионах Италии существуют собственные ..." | ||
Vol 12, No 4 (2019) | The health technology assessment system in Australia | Abstract similar documents |
V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan | ||
"... правительством, которое определяет перечни возмещаемых препаратов и медицинских услуг, а также устанавливает ..." | ||
Vol 7, No 4 (2014) | ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS | Abstract similar documents |
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva | ||
"... ценообразования. В ходе анализа цен на препараты из перечня ЖНВЛП выявлены существенные (до 25 раз) различия в ..." | ||
Vol 10, No 1 (2017) | BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS | Abstract similar documents |
E. A. Pyadushkina | ||
"... лекарственных препаратов (ЛП) из перечня жизненно необходимых и важнейших лекарственных препаратов (ПЖНВЛП ..." | ||
Vol 16, No 3 (2023) | Analysis of tariff agreements of the constituent entities of the Russian Federation: form and completeness of data presentation | Abstract similar documents |
D. V. Fedyaev, F. S. Nikitin, T. N. Artamonova, S. A. Kovaleva, V. V. Omelyanovskiy | ||
"... оплате медицинской помощи. Несмотря на наличие перечня требований к содержанию и структуре тарифного ..." | ||
Vol 8, No 4 (2015) | CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS | Abstract similar documents |
E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva | ||
"... препаратов из перечня жизненно необходимых и важнейших лекарственных препаратов (ЖНВЛП), ориентировочная ..." | ||
Vol 11, No 2 (2018) | Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer | Abstract similar documents |
G. V. Afonin, Yu. A. Ragulin, M. V. Avxentyeva, I. A. Gulidov, S. A. Ivanov, A. D. Kaprin | ||
"... безрецидивной выживаемости. Выделены основные пункты в перечне медицинских услуг, влияющие на формирование ..." | ||
Vol 9, No 3 (2016) | CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY | Abstract similar documents |
E. A. Pyadushkina, M. Yu. Frolov | ||
"... рассчитываются на основе зарегистрированных цен препаратов из перечня жизненно необходимых и важнейших ..." | ||
Vol 18, No 2 (2025) | Pharmacoeconomic study of oral anticancer therapy: results of combined ABC/VEN and frequency analysis | Abstract similar documents |
J. A. Agafonova | ||
"... соответствии с наличием содержащихся в них препаратов из Примерного перечня Всемирной организации ..." | ||
1 - 36 of 36 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)